BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Liu Y, Shao D, Qian Z, Dong Z, Sun Y, Xing X, Cheng X, Du H, Hu Y. Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer. Gastric Cancer. 2016;19:116-127. [PMID: 25618371 DOI: 10.1007/s10120-015-0467-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Yang X, Fan D, Troha AH, Ahn HM, Qian K, Liang B, Du Y, Fu H, Ivanov AA. Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer. Bioorg Med Chem 2021;45:116324. [PMID: 34333394 DOI: 10.1016/j.bmc.2021.116324] [Reference Citation Analysis]
2 Gigek CO, Calcagno DQ, Rasmussen LT, Santos LC, Leal MF, Wisnieski F, Burbano RR, Lourenço LG, Lopes-Filho GJ, Smith MAC. Genetic variants in gastric cancer: Risks and clinical implications. Exp Mol Pathol 2017;103:101-11. [PMID: 28736214 DOI: 10.1016/j.yexmp.2017.07.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
3 Cai MZ, Wen SY, Wang XJ, Liu Y, Liang H. MYC Regulates PHF8, Which Promotes the Progression of Gastric Cancer by Suppressing miR-22-3p. Technol Cancer Res Treat 2020;19:1533033820967472. [PMID: 33111613 DOI: 10.1177/1533033820967472] [Reference Citation Analysis]
4 Zhang Y, Wu Y, Jia Z, Cao D, Yang N, Wang Y, Cao X, Jiang J. Long non-coding RNA polymorphisms on 8q24 are associated with the prognosis of gastric cancer in a Chinese population. PeerJ 2020;8:e8600. [PMID: 32117633 DOI: 10.7717/peerj.8600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Teles SP, Oliveira P, Ferreira M, Carvalho J, Ferreira P, Oliveira C. Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer. Cancers (Basel) 2019;12:E70. [PMID: 31881796 DOI: 10.3390/cancers12010070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Lopes LO, Maués JH, Ferreira-Fernandes H, Yoshioka FK, Júnior SCS, Santos AR, Ribeiro HF, Rey JA, Soares PC, Burbano RR, Pinto GR. New prognostic markers revealed by RNA-Seq transcriptome analysis after MYC silencing in a metastatic gastric cancer cell line. Oncotarget 2019;10:5768-79. [PMID: 31645899 DOI: 10.18632/oncotarget.27208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rommereim LM, Akhade AS, Dutta B, Hutcheon C, Lounsbury NW, Rostomily CC, Savan R, Fraser IDC, Germain RN, Subramanian N. A small sustained increase in NOD1 abundance promotes ligand-independent inflammatory and oncogene transcriptional responses. Sci Signal 2020;13:eaba3244. [PMID: 33293463 DOI: 10.1126/scisignal.aba3244] [Reference Citation Analysis]
8 Alshabi AM, Vastrad B, Shaikh IA, Vastrad C. Identification of important invasion and proliferation related genes in adrenocortical carcinoma. Med Oncol 2019;36. [DOI: 10.1007/s12032-019-1296-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Liang L, Fang JY, Xu J. Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy. Oncogene. 2016;35:1475-1482. [PMID: 26073079 DOI: 10.1038/onc.2015.209] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 8.6] [Reference Citation Analysis]
10 Takaya H, Nakai H, Sakai K, Nishio K, Murakami K, Mandai M, Matsumura N. Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course. Gynecologic Oncology 2020;156:415-22. [DOI: 10.1016/j.ygyno.2019.11.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
11 Yu T, Ran L, Zhao H, Yin P, Li W, Lin J, Mao H, Cai D, Ma Q, Pan X, Wang X, Wu J, Zeng H, Zhang W, Lu D, Luo P, Zou Q, Xiao B. Circular RNA circ-TNPO3 suppresses metastasis of GC by acting as a protein decoy for IGF2BP3 to regulate the expression of MYC and SNAIL. Mol Ther Nucleic Acids 2021;26:649-64. [PMID: 34703650 DOI: 10.1016/j.omtn.2021.08.029] [Reference Citation Analysis]
12 C L, A C, L V, L B, d’Alessandro M, P C, G S, F D, E B. Common molecular pathways targeted by nintedanib in cancer and IPF: A bioinformatic study. Pulmonary Pharmacology & Therapeutics 2020;64:101941. [DOI: 10.1016/j.pupt.2020.101941] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Liu J, Feng W, Liu M, Rao H, Li X, Teng Y, Yang X, Xu J, Gao W, Li L. Stomach-specific c-Myc overexpression drives gastric adenoma in mice through AKT/mammalian target of rapamycin signaling. Bosn J Basic Med Sci 2021;21:434-46. [PMID: 33259779 DOI: 10.17305/bjbms.2020.4978] [Reference Citation Analysis]
14 Jung JH, Jung D, Kim H, Lee H, Kang S, Srivastava SK, Yun M, Kim S. Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7. Oncogene 2018;37:3715-28. [DOI: 10.1038/s41388-018-0225-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
15 Luan F, Li X, Cheng X, Huangfu L, Han J, Guo T, Du H, Wen X, Ji J. TNFRSF11B activates Wnt/β-catenin signaling and promotes gastric cancer progression. Int J Biol Sci 2020;16:1956-71. [PMID: 32398963 DOI: 10.7150/ijbs.43630] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Zeng FM, He JZ, Wang SH, Liu DK, Xu XE, Wu JY, Li EM, Xu LY. A Novel Three-Gene Model Predicts Prognosis and Therapeutic Sensitivity in Esophageal Squamous Cell Carcinoma. Biomed Res Int 2019;2019:9828637. [PMID: 31886273 DOI: 10.1155/2019/9828637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Pádua D, Figueira P, Ribeiro I, Almeida R, Mesquita P. The Relevance of Transcription Factors in Gastric and Colorectal Cancer Stem Cells Identification and Eradication. Front Cell Dev Biol 2020;8:442. [PMID: 32626705 DOI: 10.3389/fcell.2020.00442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
18 Wang SC, Yeu Y, Hammer STG, Xiao S, Zhu M, Hong C, Clemenceau JR, Yoon LY, Nassour I, Shen J, Agarwal D, Reznik SI, Mansour JC, Yopp AC, Zhu H, Hwang TH, Porembka MR. Hispanic/Latino Patients with Gastric Adenocarcinoma Have Distinct Molecular Profiles Including a High Rate of Germline CDH1 Variants. Cancer Res 2020;80:2114-24. [PMID: 32269045 DOI: 10.1158/0008-5472.CAN-19-2918] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Zheng Y, Cheng Y, Zhang C, Fu S, He G, Cai L, Qiu L, Huang K, Chen Q, Xie W, Chen T, Huang M, Bai Y, Pan M. Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma. J Gastrointest Oncol 2021;12:1086-100. [PMID: 34295559 DOI: 10.21037/jgo-21-205] [Reference Citation Analysis]
20 Huang J, Jiang D, Zhu T, Wang Y, Wang H, Wang Q, Tan L, Zhu H, Yao J, Hou Y. Prognostic Significance of c-MYC Amplification in Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 2019;107:436-43. [PMID: 30273571 DOI: 10.1016/j.athoracsur.2018.07.077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Su B, Xu T, Bruce JP, Yip KW, Zhang N, Huang Z, Zhang G, Liu FF, Liang J, Yang H, Claret FX. hsa‑miR‑24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c‑Myc/epithelial‑mesenchymal transition axis. Oncol Rep 2018;40:2536-46. [PMID: 30226609 DOI: 10.3892/or.2018.6690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
22 Zhang JR, Hou P, Wang XJ, Weng ZQ, Shang-Guan XC, Wang H, You F, Lin BQ, Huang ZY, Chen XQ. TNFRSF11B Suppresses Memory CD4+ T Cell Infiltration in the Colon Cancer Microenvironment: A Multiomics Integrative Analysis. Front Immunol 2021;12:742358. [PMID: 34938284 DOI: 10.3389/fimmu.2021.742358] [Reference Citation Analysis]
23 Jiang MC. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy. Tumour Biol 2016;37:13077-90. [PMID: 27596143 DOI: 10.1007/s13277-016-5301-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
24 Yang YP, Qin RH, Zhao JJ, Qin XY. BOP1 Silencing Suppresses Gastric Cancer Proliferation through p53 Modulation. Curr Med Sci 2021;41:287-96. [PMID: 33877544 DOI: 10.1007/s11596-021-2345-y] [Reference Citation Analysis]
25 Ye LP, Mao XL, Zhou XB, Wang Y, Xu SW, He SQ, Qian ZL, Zhang XG, Zhai LJ, Peng JB, Gu BB, Jin XX, Song YQ, Li SW. Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer. World J Gastrointest Oncol 2022; 14(3): 690-702 [DOI: 10.4251/wjgo.v14.i3.690] [Reference Citation Analysis]
26 Yu SR, Huang XJ, Zhang YP. Gastric cancer related genes. Shijie Huaren Xiaohua Zazhi 2016; 24(32): 4381-4388 [DOI: 10.11569/wcjd.v24.i32.4381] [Reference Citation Analysis]
27 Xie H, Yuan C, Li JJ, Li ZY, Lu WC. Potential Molecular Mechanism of TNF Superfamily-Related Genes in Glioblastoma Multiforme Based on Transcriptome and Epigenome. Front Neurol 2021;12:576382. [PMID: 33643183 DOI: 10.3389/fneur.2021.576382] [Reference Citation Analysis]
28 Li Z, Tan H, Zhao W, Xu Y, Zhang Z, Wang M, Zhou X. Integrative analysis of DNA methylation and gene expression profiles identifies MIR4435-2HG as an oncogenic lncRNA for glioma progression. Gene 2019;715:144012. [DOI: 10.1016/j.gene.2019.144012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
29 Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfò I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F. The RNA-binding protein ESRP1 promotes human colorectal cancer progression. Oncotarget 2017;8:10007-24. [PMID: 28052020 DOI: 10.18632/oncotarget.14318] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]
30 [DOI: 10.1101/764779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Hu B, Patel KP, Chen H, Wang X, Luthra R, Routbort MJ, Kanagal‐shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating M, Wierda WG. Association of gene mutations with time‐to‐first treatment in 384 treatment‐naive chronic lymphocytic leukaemia patients. Br J Haematol 2019;187:307-18. [DOI: 10.1111/bjh.16042] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
32 Hu B, Patel KP, Chen H, Wang X, Wang F, Luthra R, Routbort MJ, Kanagal‐shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating MJ, Wierda WG. Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments. Br J Haematol 2018;185:852-64. [DOI: 10.1111/bjh.15877] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]